What sector does HASS Corp. belong to?

HASS Corp. operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 450330?

As of the latest available quote, 450330 traded at ₩5,180.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 450330?

HASS Corp. has a price-to-earnings (P/E) ratio of about 26.70. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 450330?

The market capitalisation of HASS Corp. is approximately ₩41.33B.

Is HASS Corp. profitable?

For its latest reported financial year, HASS Corp. recorded a net profit margin of about 9.33%.

Does 450330 pay a dividend?

HASS Corp. currently has a dividend yield of about 0.80%.

What is the return on equity (ROE) of 450330?

HASS Corp. has a return on equity (ROE) of about 3.34%. ROE measures how much profit a company generates relative to shareholders' equity.

HASS Corp.

450330 KRX Pharmaceuticals Pharmaceuticals

KOSDAQ

₩5,180.00

+0.97%

Delayed · cached 15 min

Fair value analysis

450330

HASS Corp.

₩5,180.00

Close used for this calculation

₩3,814.11Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

26/100

Profitability6/25

Returns1/25

Balance Sheet15/25

Efficiency4/25

Growth0/25

Weak

Quality radar

Consensus fair value

₩3,814.11

Above FV

▼ -26.4% against the close used

Model range ₩276.48 – ₩4,984.67

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩276.48Fair value₩3,814.11Bull₩4,984.67

FairClose

52-week traded range

52W low ₩3,790.0052W high ₩7,800.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

HASS Corp. closed at ₩5,180.00, 35.8% above the consensus fair value of ₩3,814.11 drawn from 7 valuation models.

Financial DNA score 26/100 — Weak. P/E of 26.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩3,636.05

-29.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩4,984.67

-3.8%

√(22.5 × EPS × BVPS)

EPS=194, BVPS=5692.31 · outside Graham range (P/E 26.7, P/B 0.9) — asset-light, treat as a rough floor

P/E Fair Value

₩3,880.00

-25.1%

EPS × 20x (sector P/E)

EPS=194, Sector P/E=20x

EV/EBITDA

₩475.03

-90.8%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=902.81M

Book Value (P/B)

₩276.48

-94.7%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=5692.31, ROE=3.3%, g=3%, r=10%

Reverse DCF

₩5,180.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 11% | Historical: 0%

Margin of Safety

₩3,125.18

-39.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=4166.91, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer